Singapore, Aug. 7 -- TAKEDA PHARMACEUTICAL COMPANY LIMITED made the following announcement:
Security Name: NA
General Announcement::U.S. FDA Approves Takeda ORZEYFUL (oveporexton) (https://links.sgx.com/1.0.0/corporate-announcements/9UF6YYDE5SZHAS8R/07133aba3d976d1a5e4ed1b670789792f4aad7d62d78a7d9114828bdc886e754)
Published by HT Digital Content Services with permission from South East Asian News....